GW Pharma has got the ball rolling on the first of its programme of European approvals for Sativex, with clearance in the Czech Republic for the medicine's use in relieving muscle stiffness caused by multiple sclerosis. The company seeks further approvals in Germany, Italy, Denmark, Austria and Sweden.
IC TIP:
Buy
at
114p
What we said: Buy
When: 10 Sep 2010
Price: 93p
Tip performance to date: +23 per cent
